Baker Bros. Advisors as of Sept. 30, 2018
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 97 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Seattle Genetics | 25.9 | $3.9B | 51M | 77.12 | |
| Incyte Corporation (INCY) | 15.6 | $2.4B | 34M | 69.08 | |
| Beigene (BGNE) | 13.6 | $2.1B | 12M | 172.22 | |
| Alexion Pharmaceuticals | 7.8 | $1.2B | 8.6M | 139.01 | |
| Genomic Health | 6.4 | $968M | 14M | 70.22 | |
| BioMarin Pharmaceutical (BMRN) | 4.8 | $735M | 7.6M | 96.97 | |
| ACADIA Pharmaceuticals (ACAD) | 3.9 | $590M | 28M | 20.76 | |
| Amarin Corporation (AMRN) | 3.6 | $554M | 34M | 16.27 | |
| Madrigal Pharmaceuticals (MDGL) | 1.6 | $250M | 1.2M | 214.13 | |
| Ascendis Pharma A S (ASND) | 1.3 | $201M | 2.8M | 70.86 | |
| Heron Therapeutics (HRTX) | 1.1 | $159M | 5.0M | 31.65 | |
| Invitae (NVTAQ) | 0.9 | $141M | 8.4M | 16.73 | |
| Dbv Technologies S A (DBVT) | 0.8 | $124M | 5.5M | 22.46 | |
| Mirati Therapeutics | 0.8 | $118M | 2.5M | 47.10 | |
| Neurocrine Biosciences (NBIX) | 0.8 | $116M | 945k | 122.95 | |
| BioCryst Pharmaceuticals (BCRX) | 0.8 | $115M | 15M | 7.63 | |
| Array BioPharma | 0.6 | $86M | 5.7M | 15.20 | |
| Sage Therapeutics (SAGE) | 0.5 | $80M | 568k | 141.25 | |
| Rhythm Pharmaceuticals (RYTM) | 0.5 | $79M | 2.7M | 29.17 | |
| Cerus Corporation (CERS) | 0.5 | $78M | 11M | 7.21 | |
| Argenx Se (ARGX) | 0.5 | $77M | 1.0M | 75.84 | |
| Spark Therapeutics | 0.5 | $76M | 1.4M | 54.55 | |
| Kiniksa Pharmaceuticals (KNSA) | 0.5 | $77M | 3.0M | 25.50 | |
| Gw Pharmaceuticals Plc ads | 0.5 | $69M | 397k | 172.74 | |
| Cymabay Therapeutics | 0.4 | $55M | 4.9M | 11.08 | |
| Principia Biopharma | 0.3 | $52M | 1.8M | 29.22 | |
| Tricida | 0.3 | $49M | 1.6M | 30.55 | |
| Endocyte | 0.3 | $45M | 2.5M | 17.76 | |
| Idera Pharmaceuticals | 0.3 | $43M | 4.8M | 8.91 | |
| Corsicanto Ii Designated Act note | 0.3 | $42M | 10M | 4.17 | |
| Insmed (INSM) | 0.2 | $37M | 1.9M | 20.22 | |
| Aquinox Pharmaceuticals | 0.2 | $32M | 11M | 2.93 | |
| Galapagos Nv- (GLPG) | 0.2 | $27M | 237k | 112.43 | |
| Abeona Therapeutics | 0.2 | $28M | 2.2M | 12.80 | |
| Solid Biosciences | 0.2 | $28M | 588k | 47.18 | |
| Xencor (XNCR) | 0.1 | $24M | 603k | 38.97 | |
| Uniqure Nv (QURE) | 0.1 | $22M | 605k | 36.39 | |
| Myokardia | 0.1 | $23M | 357k | 65.20 | |
| Merus N V (MRUS) | 0.1 | $23M | 1.2M | 19.74 | |
| Sangamo Biosciences (SGMO) | 0.1 | $22M | 1.3M | 16.95 | |
| Zymeworks | 0.1 | $21M | 1.3M | 15.70 | |
| Clementia | 0.1 | $22M | 1.9M | 11.15 | |
| Aimmune Therapeutics | 0.1 | $18M | 674k | 27.28 | |
| Bellicum Pharma | 0.1 | $17M | 2.7M | 6.16 | |
| Neurocrine Biosciences Inc Note 2.250 5/1 | 0.1 | $17M | 10M | 1.71 | |
| Contrafect | 0.1 | $15M | 7.2M | 2.07 | |
| Audentes Therapeutics | 0.1 | $16M | 393k | 39.59 | |
| Biomarin Pharma Inc convertible/ | 0.1 | $16M | 15M | 1.05 | |
| Aeglea Biotherapeutics | 0.1 | $13M | 1.4M | 9.57 | |
| Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.1 | $13M | 12M | 1.03 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.1 | $11M | 2.9M | 3.78 | |
| Anaptysbio Inc Common (ANAB) | 0.1 | $11M | 113k | 99.77 | |
| Novavax | 0.1 | $8.9M | 4.7M | 1.88 | |
| Bluebird Bio (BLUE) | 0.1 | $8.7M | 59k | 145.99 | |
| Erytech Pharma Sa | 0.1 | $9.3M | 1.1M | 8.57 | |
| Halozyme Therapeutics (HALO) | 0.1 | $8.2M | 450k | 18.17 | |
| Momenta Pharmaceuticals | 0.1 | $8.1M | 309k | 26.30 | |
| Viking Therapeutics (VKTX) | 0.1 | $7.4M | 425k | 17.42 | |
| Spring Bk Pharmaceuticals In | 0.1 | $7.4M | 613k | 12.05 | |
| Syros Pharmaceuticals | 0.1 | $6.8M | 575k | 11.91 | |
| Albireo Pharma | 0.1 | $8.2M | 250k | 32.96 | |
| Menlo Therapeutics | 0.1 | $6.9M | 700k | 9.85 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 0.1 | $7.2M | 235k | 30.67 | |
| Achillion Pharmaceuticals | 0.0 | $6.0M | 1.6M | 3.68 | |
| Assembly Biosciences | 0.0 | $5.5M | 149k | 37.14 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.0 | $5.9M | 308k | 19.17 | |
| Intellia Therapeutics (NTLA) | 0.0 | $5.5M | 193k | 28.62 | |
| G1 Therapeutics (GTHX) | 0.0 | $6.7M | 127k | 52.29 | |
| Inflarx Nv (IFRX) | 0.0 | $6.1M | 179k | 34.32 | |
| Alkermes (ALKS) | 0.0 | $4.3M | 100k | 42.44 | |
| Chemocentryx | 0.0 | $5.2M | 414k | 12.64 | |
| Acceleron Pharma | 0.0 | $4.8M | 84k | 57.23 | |
| Galmed Pharmaceuticals | 0.0 | $4.4M | 324k | 13.58 | |
| Foamix Pharmaceuticals | 0.0 | $3.9M | 688k | 5.73 | |
| Aevi Genomic | 0.0 | $4.9M | 4.0M | 1.23 | |
| Y Mabs Therapeutics (YMAB) | 0.0 | $4.0M | 150k | 26.56 | |
| La Jolla Pharmaceuticl Com Par | 0.0 | $3.1M | 155k | 20.13 | |
| Versartis | 0.0 | $3.4M | 2.4M | 1.40 | |
| Adamas Pharmaceuticals | 0.0 | $3.5M | 173k | 20.02 | |
| Trillium Therapeutics, Inc. Cmn | 0.0 | $2.9M | 505k | 5.80 | |
| Ra Pharmaceuticals | 0.0 | $3.2M | 178k | 18.09 | |
| Apellis Pharmaceuticals (APLS) | 0.0 | $3.5M | 196k | 17.78 | |
| Forty Seven | 0.0 | $3.7M | 250k | 14.92 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.0 | $3.8M | 131k | 28.65 | |
| Infinity Pharmaceuticals (INFIQ) | 0.0 | $1.6M | 580k | 2.71 | |
| Affimed Therapeutics B V | 0.0 | $870k | 200k | 4.35 | |
| Dynavax Technologies (DVAX) | 0.0 | $930k | 75k | 12.40 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $1.1M | 557k | 2.00 | |
| Ovid Therapeutics (OVID) | 0.0 | $1.3M | 222k | 5.67 | |
| Molecular Templates | 0.0 | $1.4M | 254k | 5.39 | |
| Krystal Biotech (KRYS) | 0.0 | $2.0M | 115k | 17.58 | |
| Arcus Biosciences Incorporated (RCUS) | 0.0 | $1.7M | 122k | 13.94 | |
| Aquestive Therapeutics (AQST) | 0.0 | $1.7M | 100k | 17.51 | |
| Constellation Pharmceticls I | 0.0 | $897k | 133k | 6.73 | |
| Proteon Therapeutics | 0.0 | $582k | 299k | 1.95 | |
| Fulgent Genetics (FLGT) | 0.0 | $491k | 125k | 3.93 | |
| Ritter Pharmaceuticals | 0.0 | $521k | 280k | 1.86 |
